Match!

The atypical antipsychotic blonanserin reverses (+)-PD-128907- and ketamine-induced deficit in executive function in common marmosets

Published on May 1, 2016in Behavioural Brain Research2.77
· DOI :10.1016/j.bbr.2016.02.031
Manato Kotani4
Estimated H-index: 4
,
Takeshi Enomoto7
Estimated H-index: 7
+ 9 AuthorsKazuhito Ikeda6
Estimated H-index: 6
Abstract
Abstract Antagonism of the dopamine D 3 receptor is considered a promising strategy for the treatment of cognitive impairment associated with schizophrenia. We have previously reported that the atypical antipsychotic blonanserin, a dopamine D 2 /D 3 and serotonin 5-HT 2A receptor antagonist, highly occupies dopamine D 3 receptors at its antipsychotic dose range in rats. In the present study, we evaluated the effects of blonanserin on executive function in common marmosets using the object retrieval with detour (ORD) task. The dopamine D 3 receptor-preferring agonist (+)-PD-128907 at 1 mg/kg decreased success rate in the difficult trial, but not in the easy trial. Since the difference between the two trials is only cognitive demand, our findings indicate that excess activation of dopamine D 3 receptors impairs executive function in common marmosets. Blonanserin at 0.1 mg/kg reversed the decrease in success rate induced by (+)-PD-128907 in the difficult trial. This finding indicates that blonanserin has beneficial effect on executive function deficit induced by activation of the dopamine D 3 receptor in common marmosets. Next, and based on the glutamatergic hypothesis of schizophrenia, the common marmosets were treated with the N-methyl- d- aspartate (NMDA) receptor antagonist ketamine. Ketamine at sub-anesthetic doses decreased success rate in the difficult trial, but not in the easy trial. Blonanserin at 0.1 mg/kg reversed the decrease in success rate induced by ketamine in the difficult trial. The findings of this study suggest that blonanserin might have beneficial effect on executive dysfunction in patients with schizophrenia.
  • References (44)
  • Citations (4)
📖 Papers frequently viewed together
10 Citations
18 Citations
19 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References44
Newest
#1Manato KotaniH-Index: 4
#2Akihiko KiyoshiH-Index: 4
Last. Kazuhito IkedaH-Index: 6
view all 9 authors...
Eye blinking is a spontaneous behavior observed in all mammals, and has been used as a well-established clinical indicator for dopamine production in neuropsychiatric disorders, including Parkinson’s disease and Tourette syndrome [1] ; [2]. Pharmacological studies in humans and non-human primates have shown that dopamine agonists/antagonists increase/decrease eye blinking rate. Common marmosets (Callithrix jacchus) have recently attracted a great deal of attention as suitable experimental animal...
11 CitationsSource
#1Mei Huang (NU: Northwestern University)H-Index: 22
#2Sunoh Kwon (NU: Northwestern University)H-Index: 8
Last. Herbert Y. Meltzer (NU: Northwestern University)H-Index: 128
view all 6 authors...
Abstract Blonanserin is a novel atypical antipsychotic drug (APD), which, unlike most atypical APDs, has a slightly higher affinity for dopamine (DA) D 2 than serotonin (5-HT) 2A receptors, and is an antagonist at both, as well as at D 3 receptors. The effects of atypical APDs to enhance rodent cortical, hippocampal, limbic, and dorsal striatal (dSTR) DA and acetylcholine (ACh) release, contribute to their ability to improve novel object recognition (NOR) in rodents treated with sub-chronic (sc)...
15 CitationsSource
#1Ragy R. Girgis (Columbia University)H-Index: 27
#2Xiaoyan Xu (Columbia University)H-Index: 19
Last. Anissa Abi-Dargham (Columbia University)H-Index: 64
view all 8 authors...
Background All currently available antipsychotic medications bind to both the dopamine-2 (D2) and dopamine-3 (D3) receptors in vitro. However, there is conflicting evidence from in vivo studies about whether or not antipsychotic medications bind to the D3 receptor (D3R). The purpose of this study was to determine whether acute doses of risperidone bind to the D3R in humans.
13 CitationsSource
#1Satoko BabaH-Index: 2
#2Takeshi MuraiH-Index: 5
Last. Kazuhito IkedaH-Index: 6
view all 7 authors...
10 CitationsSource
#1Satoko BabaH-Index: 2
#2Takeshi EnomotoH-Index: 7
Last. Michiko OnoH-Index: 8
view all 5 authors...
Abstract Antagonism of the dopamine D 3 receptor has been hypothesized to be beneficial for schizophrenia cognitive deficits, negative symptoms and extrapyramidal symptoms. However, recent animal and human studies have shown that most antipsychotics do not occupy D 3 receptors in vivo, despite their considerable binding affinity for this receptor in vitro. In the present study, we investigated the D 3 receptor binding of blonanserin, a dopamine D 2 /D 3 and serotonin 5-HT 2A receptors antagonist...
12 CitationsSource
#1Hirotake Hida (Meijo University)H-Index: 5
#2Akihiro Mouri (Meijo University)H-Index: 28
Last. Yukihironoda (Meijo University)H-Index: 48
view all 11 authors...
Blonanserin differs from currently used serotonin 5-HT2A/dopamine-D2 receptor antagonists in that it exhibits higher affinity for dopamine-D2/3 receptors than for serotonin 5-HT2A receptors. We investigated the involvement of dopamine-D3 receptors in the effects of blonanserin on cognitive impairment in an animal model of schizophrenia. We also sought to elucidate the molecular mechanism underlying this involvement. Blonanserin, as well as olanzapine, significantly ameliorated phencyclidine (PCP...
18 CitationsSource
Executive functions are an emerging propriety of neuronal processing in circuits encompassing frontal cortex and other cortical and subcortical brain regions such as basal ganglia and thalamus. Glutamate serves as the major neurotrasmitter in these circuits where glutamate receptors of NMDA type play key role. Serotonin and dopamine afferents are in position to modulate intrinsic glutamate neurotransmission along these circuits and in turn to optimise circuit performance for specific aspects of ...
31 CitationsSource
#1Stefano Cavallari (IIT: Istituto Italiano di Tecnologia)H-Index: 3
#2Stefano Panzeri (IIT: Istituto Italiano di Tecnologia)H-Index: 51
Last. Alberto Mazzoni (IIT: Istituto Italiano di Tecnologia)H-Index: 16
view all 3 authors...
Models of networks of Leaky Integrate-and-Fire neurons (LIF) are a widely used tool for theoretical investigations of brain function. These models have been used both with current- and conductance-based synapses. However, the differences in the dynamics expressed by these two approaches have been so far mainly studied at the single neuron level. To investigate how these synaptic models affect network activity, we compared the single-neuron and neural population dynamics of conductance-based netw...
59 CitationsSource
#1Takeshi Murai (Dainippon Sumitomo Pharma Co., Ltd.)H-Index: 5
#2Tomokazu Nakako (Dainippon Sumitomo Pharma Co., Ltd.)H-Index: 7
Last. Mutsuo Taiji (Dainippon Sumitomo Pharma Co., Ltd.)H-Index: 24
view all 6 authors...
19 CitationsSource
#1Hikaru Hori (University of Occupational and Environmental Health Japan)H-Index: 22
#2Kenji YamadaH-Index: 5
Last. JunnakamuraH-Index: 12
view all 7 authors...
Background: This study aims to determine the effectiveness of blonanserin (BNS) on the cognitive and social functions of patients with schizophrenia compared with risperidone (RIS) during acute-phase (8-week) treatment. Methods: A total of 39 schizophrenia inpatients were included in this study. The subjects received either BNS (N=20) or RIS (N=19), and the clinical responses were evaluated periodically. The concomitant use of mood stabilizers was not allowed. Efficacy was assessed with the Posi...
14 CitationsSource
Cited By4
Newest
#1Mark J. MillanH-Index: 80
#2Anne DekeyneH-Index: 32
Last. Kevin C. F. Fone (University of Nottingham)H-Index: 41
view all 8 authors...
Abstract To date, there are no interventions that impede the inexorable progression of Alzheimer's disease (AD), and currently-available drugs cholinesterase (AChE) inhibitors and the N-Methyl- d -Aspartate receptor antagonist, memantine, offer only modest symptomatic benefit. Moreover, a range of mechanistically-diverse agents (glutamatergic, histaminergic, monoaminergic, cholinergic) have disappointed in clinical trials, alone and/or in association with AChE inhibitors. This includes serotonin...
Source
#1Stephan J. Sanders (UCSF: University of California, San Francisco)H-Index: 45
#2Mustafa Sahin (Boston Children's Hospital)H-Index: 52
Last. Carrie E. Bearden (Semel Institute for Neuroscience and Human Behavior)H-Index: 59
view all 26 authors...
De novo and inherited rare genetic disorders (RGDs) are a major cause of human morbidity, frequently involving neuropsychiatric symptoms. Recent advances in genomic technologies and data sharing have revolutionized the identification and diagnosis of RGDs, presenting an opportunity to elucidate the mechanisms underlying neuropsychiatric disorders by investigating the pathophysiology of high-penetrance genetic risk factors. Here we seek out the best path forward for achieving these goals. We thin...
3 CitationsSource
#1Grzegorz R. Juszczak (PAN: Polish Academy of Sciences)H-Index: 12
#2Rafał Stryjek (PAN: Polish Academy of Sciences)H-Index: 10
Abstract Increased perseveration is associated with aging and leads to an impaired ability to cope with problems. Aging is also associated with progressing dysfunction of the cholinergic system which is involved in the regulation of various cognitive processes. Therefore, we tested an effect of an anticholinergic drug on the level of perseveration in mice subjected to the detour test. The subjects tested on this task are expected to disengage from visually guided behavior and to move around a tr...
1 CitationsSource
In our drug discovery program, we identified a novel orally available and brain-penetrant phosphodiesterase (PDE) 1 inhibitor, 3-methyl-7-(tetrahydro-2H-pyran-4-yl)-2-{[trans-4-(trifluoromethyl)cyclohexyl]-methoxy}imidazo[5,1-f][1,2,4]triazin-4(3H)-one (DSR-141562). In the present study, we characterized the preclinical profile of DSR-141562. This compound has preferential selectivity for predominantly brain-expressed PDE1B over other PDE1 family members, and high selectivity for the PDE1 family...
Source
Abstract Long-term treatment with antipsychotic drugs in patients with schizophrenia can lead to dopamine supersensitivity psychosis. It is reported that repeated administration of haloperidol caused dopamine supersensitivity in rats. Blonanserin is an atypical antipsychotic drug with high affinity for dopamine D 2 , D 3 and serotonin 2A receptors. In this study, we investigated whether chronic administration of blonanserin leads to dopamine supersensitivity. Following oral treatment with blonan...
Source
#1Gian Marco LeggioH-Index: 20
#2Claudio BucoloH-Index: 32
Last. Filippo DragoH-Index: 47
view all 5 authors...
Abstract Dopamine receptors (DR) have been extensively studied, but only in recent years they became object of investigation to elucidate the specific role of different subtypes (D1R, D2R, D3R, D4R, D5R) in neural transmission and circuitry. D1-like receptors (D1R and D5R) and D2-like receptors (D2R, D2R and D4R) differ in signal transduction, binding profile, localization in the central nervous system and physiological effects. D3R is involved in a number of pathological conditions, including s...
25 CitationsSource